Skip to content
Venture Capital

Updated:

The University of Vermont Health Network Ventures

The University of Vermont Health Network Ventures is the venture arm of the University of Vermont Health Network, an 8-hospital healthcare system.

The University of Vermont Health Network Ventures

The University of Vermont Health Network Ventures is the venture arm of the University of Vermont Health Network, an 8-hospital healthcare system. It has made 3 investments. The latest investment was in THEYA Healthcare in June 18, 2021.

General information

Firm type

Venture Capital

Location

Region

North America

Country

United States

City

Palo Alto

Corporate office

Palo Alto, CA, United States

Additional offices

Burlington, VT, United States

Sector focus

Digital HealthHealthcare ServicesEnterprise Software

Frequently asked questions

How does The University of Vermont Health Network Ventures source proprietary deal flow?

UVMHN Ventures sources deals through its parent health network's clinical and operational leadership, who identify technology needs. Portfolio companies gain access to the network's six hospitals for pilot programs and product feedback. The fund also reviews external pitches from healthtech startups, but proprietary flow comes from internal use-case identification.

Does The University of Vermont Health Network Ventures participate in fund commitments or only direct deals?

The venture arm primarily makes direct minority investments in early-stage healthcare technology companies. There is no public evidence that UVMHN Ventures commits to external venture funds. Its model emphasizes direct equity stakes in startups that can become vendors or partners to the parent health network.

What investment stages does The University of Vermont Health Network Ventures typically target?

The fund targets seed through Series B rounds. It focuses on early-stage companies that have a developed product and some initial traction but need capital to scale. Later-stage investments are unlikely, as the strategic benefit of early integration with the parent network is highest when the portfolio company is still flexible.

Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Source record modified: . Public records carry source-specific dates where available. No population-wide measured refresh cadence or universal verification deadline is established here. Page modified, source captured, fact observed, entity verified and aggregate measured describe different events. Check the date attached to the relevant claim; a missing verification date means unknown. Stored source history does not establish a customer-facing historical-analysis interface. To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Need institutional-grade insight on venture capital firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Venture Capital profiles